R&D
R&D status
We are continuously innovating through various research projects and enhancing the quality and stability of our products based on cutting-edge technology and rigorous verification.
-
Research Step01
- Research
- Securing candidate substances
-
Non-clinical trials Step02
- Non-clinical trials
- Efficacy and safety evaluation
-
Clinical trials Step03
- Clinical trials
- Phase 1/2/3 clinical trials
-
Approval Step04
- Approval
- Product approval
| Item | Project | Indication | Research | Non-clinical study | Clinical study | ||
|---|---|---|---|---|---|---|---|
| Phase 1 | Phase 2 | Phase 3 | |||||
| Incrementally modified drugs |
NEX004 | Peptic ulcer | |||||
| New natural substances |
G47 Extract | Hyperlipidemia | |||||
| G46 Extract | Osteoarthritis | ||||||
| Biopharmaceutical new drug |
TRAP80 | Arteriosclerosis | |||||
| Biobetter | NEX005 | Diabetes | |||||
| Individually recognized ingredient |
NEX006 | Macular degeneration | |||||
| NEX006 compound | Macular degeneration | ||||||
| NEX007 | Triglycerides | ||||||
